- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04461665
Effects of Vitamin D Supplementation on Immune Function in Infants
Study Overview
Detailed Description
Study plan to enroll breastfeeding infant at age of 4 month, and provide vitamin D (vitD) supplement 10 μg daily until 6 month. we also enroll 6 month-old infant as control group.
All infants collected 5 ml artery blood and measured vitD nutritional status and immune function. Blood analysis contain complete blood count (CBC), differential count (DC), serum calcium, serum Parathyroid hormone (PTH), serum 25(OH)D3, serum total immunoglobulinE (IgE) and cell phagocytosis.
Peripheral blood mononuclear cell (PBMC) in blood was separated and cultured with complete medium contain 10% fetal bovine serum (CM10), or with different mitogens, include lipopolysaccharide (LPS), phorbol 12-myristate 13-acetate and ionomycin (PI) and house dust mite extract (HDM). PBMC are incubated at 37 ℃, 5% CO2 for 48 hours, and determined the expression of B cell with IgE receptor CD21 and CD23 and T regulatory cell with transcription factor Foxp3 by flow cytometry. All data were analyzed with SPSS 20.0. Infant sex and feeding type were analyzed by chi-square analysis. Difference between vitD supplement group and control group were analyzed by student's t test. Relationship between 25(OH)D3 and Calcium or PTH were analyzed by pearson correlation analysis. There was a significant difference when p-value was less than 0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taipei, Taiwan, 104
- Shih Chien University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Breastfeeding healthy infants
Exclusion Criteria:
- heart disease
- liver disease
- lung disease
- Intestinal disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Enroll 6 months old breast feeding infant, who have not supplement vitamin D at pediatric clinic.
|
|
|
Experimental: VitD supplement
Enroll 4 months old breast feeding infant, and provide 10 μg vitamin D daily for 2 months.
|
vitamin D supplement 10 μg daily for 2 months
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characteristic of infants-1
Time Frame: Infants at 4 months old
|
Gender in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-2
Time Frame: Infants at 4 months old
|
Gestational week (week) in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-3
Time Frame: Infants at 4 months old
|
Birth length (cm) in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-4
Time Frame: Infants at 4 months old
|
Birth weight (kg) in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-5
Time Frame: Infants at 4 months old
|
Birth head circumference (cm) in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-6
Time Frame: Infants at 4 months old
|
Exposed to the sun (min/day) in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-7
Time Frame: Infants at 4 months old
|
Exclusive breast-fed n (%) in baseline
|
Infants at 4 months old
|
|
Characteristic of infants-8
Time Frame: Infants at 4 months old
|
Mixed-fed n (%) in baseline
|
Infants at 4 months old
|
|
The anthropometric of infants from 4 months old to 6 months old-1
Time Frame: Infants at 4 and 6 months old
|
Length percentile (%) in both groups
|
Infants at 4 and 6 months old
|
|
The anthropometric of infants from 4 months old to 6 months old-2
Time Frame: Infants at 4 and 6 months old
|
Weight percentile (%) in both groups
|
Infants at 4 and 6 months old
|
|
Vitamin D nutritional status of infants-1
Time Frame: Infants at 4 and 6 months old
|
Ca (mg/dL) in both groups
|
Infants at 4 and 6 months old
|
|
Vitamin D nutritional status of infants-2
Time Frame: Infants at 4 and 6 months old
|
PTH (pg/mL) in both groups
|
Infants at 4 and 6 months old
|
|
Vitamin D nutritional status of infants-3
Time Frame: Infants at 4 and 6 months old
|
25(OH)D3 (ng/mL) in both groups
|
Infants at 4 and 6 months old
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cell markers expression of B cells
Time Frame: Infants at 6 months old
|
D21 and CD23 expression (%) in both groups
|
Infants at 6 months old
|
|
Cell markers expression of T cells
Time Frame: Infants at 6 months old
|
Foxp3 expression (%) in both groups
|
Infants at 6 months old
|
|
Serum immunoglobulin E level of infants
Time Frame: Infants at 6 months old
|
Concentration of IgE (ng/ml) in both groups
|
Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by CM-10 induction-1
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-6 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by CM-10 induction-2
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-4 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by CM-10 induction-3
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-13 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by CM-10 induction-4
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-10 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by CM-10 induction-5
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of TGF-β (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by LPS induction-1
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-6 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by LPS induction-2
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of TNF-α (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by PI induction-1
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-4 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by PI induction-2
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-13 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by PI induction-3
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-10 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by PI induction-4
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of TGF-β (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by HDM induction-1
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IFN-γ (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by HDM induction-2
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-4 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by HDM induction-3
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-13 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by HDM induction-4
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of IL-10 (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
|
Cytokine levels in supernatant of lymphocyte by HDM induction-5
Time Frame: Lymphocyte isolation from Infants at 6 months old
|
Concentration of TGF-β (pg/ml) in both groups
|
Lymphocyte isolation from Infants at 6 months old
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Chao-Ming Chen, MD/PHD, Shih Chien University
Publications and helpful links
General Publications
- Vasiliou JE, Lui S, Walker SA, Chohan V, Xystrakis E, Bush A, Hawrylowicz CM, Saglani S, Lloyd CM. Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease. Allergy. 2014 Oct;69(10):1380-9. doi: 10.1111/all.12465. Epub 2014 Aug 4.
- Chawes BL, Bonnelykke K, Jensen PF, Schoos AM, Heickendorff L, Bisgaard H. Cord blood 25(OH)-vitamin D deficiency and childhood asthma, allergy and eczema: the COPSAC2000 birth cohort study. PLoS One. 2014 Jun 12;9(6):e99856. doi: 10.1371/journal.pone.0099856. eCollection 2014.
- Dawodu A, Davidson B, Woo JG, Peng YM, Ruiz-Palacios GM, de Lourdes Guerrero M, Morrow AL. Sun exposure and vitamin D supplementation in relation to vitamin D status of breastfeeding mothers and infants in the global exploration of human milk study. Nutrients. 2015 Feb 5;7(2):1081-93. doi: 10.3390/nu7021081.
- Somashekar AR, Prithvi AB, Gowda MN. Vitamin d levels in children with bronchial asthma. J Clin Diagn Res. 2014 Oct;8(10):PC04-7. doi: 10.7860/JCDR/2014/10387.5055. Epub 2014 Oct 20.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20150301R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
University Hospital, Clermont-FerrandTerminated
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingVitamin d DeficiencyChina
-
University of DelawareCompleted
-
University of Missouri, Kansas CityTruman Medical CenterWithdrawnVitamin d DeficiencyUnited States
Clinical Trials on vitamin D
-
University of Ilorin Teaching HospitalMayo ClinicNot yet recruitingProstate Cancer (Adenocarcinoma) | Vitamin D on Tumor Response and Inflammatory MarkersNigeria
-
PfizerTerminated
-
Wroclaw University of Health and Sport SciencesCompletedAthletes | Football Players | Exercise Physiology | Vitamin D Deficiency (10 ng/mL to 30 ng/mL)Poland
-
Universidad Autónoma Benito Juárez de OaxacaNational Council of Science and Technology, MexicoCompletedObesity | Muscle Weakness | Vitamin D Deficiency | Sarcopenia | Aging | Sarcopenic Obesity | Obesity (Disorder) | Sarcopenia in Elderly | Muscle Mass | Functional Decline | Age-Related Loss of Skeletal Muscle Mass | Older Adults (65 Years and Older) | Muscle Strengh | Vitamin D 25-Hydroxylase DeficiencyMexico
-
Umeå UniversityRegion SkaneCompleted
-
Bangladesh Medical UniversityEnrolling by invitationHypovitaminosis D | Major Depressive Disorder (MDD)Bangladesh
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Karadeniz Technical UniversityActive, not recruitingThose Who Provided Written Informed Consent | Female Gender | Aged 18 Years and Older | Hypothyroidism Disease | Serum Vitamin d < 30 ng/dlTurkey (Türkiye)
-
Khon Kaen UniversityCompletedEndometriosis | Vitamin D Status | Vitamin D Deficiency/InsufficiencyThailand
-
Bursa City HospitalCompletedVitamin D Deficiency | COVIDTurkey (Türkiye)